Cyclarity Therapeutics
PrivateLast Round
Series A
Dec 30, 2024
Est. Valuation
$30.4M
Total Funding Raised
$24.35M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cyclarity Therapeutics operates in Healthcare & Life Sciences and is based in Novato, California. Its latest recorded funding round was a Series A round in December 2024.
Cyclarity Therapeutics is a biotechnology company that develops drugs to prevent and treat age-related conditions such as atherosclerosis by targeting and removing toxic forms of cholesterol.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyclarity Therapeutics Comparables
Compare Cyclarity Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Repair Biotechnologies | 83% | |
| Bitterroot Bio | 83% | |
| Beijing Innova Medicine Technology Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Cyclarity Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 30, 2024 | ||||
| SAFE | Jul 19, 2023 | ||||
| Seed | Sep 23, 2021 | ||||
| Seed | Nov 14, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cyclarity Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Starbloom Capital | Series A |
| VitaDAO | SAFE, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 107% MoM.
- May 16, 2026
Monthly visitors increased 38% MoM, reaching 4K.
For institutional investors. Book with your work email.
Cyclarity Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cyclarity Therapeutics's valuation, stock price, and market status.
Is Cyclarity Therapeutics a public or private company?
Cyclarity Therapeutics is a private company.
What is the current stock price of Cyclarity Therapeutics?
Cyclarity Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cyclarity Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cyclarity Therapeutics worth (valuation)?
Cyclarity Therapeutics's valuation is estimated at $30.4M based on funding round data.
Can I buy Cyclarity Therapeutics stock?
Cyclarity Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cyclarity Therapeutics's last funding round?
Cyclarity Therapeutics's most recent funding round was Series A on December 30, 2024.
Who are the main investors in Cyclarity Therapeutics?
Key investors in Cyclarity Therapeutics include Kizoo Technology Capital, Starbloom Capital.
Will Cyclarity Therapeutics IPO soon?
No public IPO plans have been announced for Cyclarity Therapeutics.
How can I track Cyclarity Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cyclarity Therapeutics's shares on secondary markets.